Interestingly, markedly elevated level of the p-eIF2α has been previously demonstrated, as compared to noncancerous cells, in cancer cells including bronchioloalveolar carcinoma, Hodgkin’s lymphoma, gastrointestinal carcinoma as well as benign and malignant melanocytic and colonic epithelial neoplasms [204,205,206,207]. The gene discussed is EIF2A; the disease is cancer.